Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance

International Journal of Infectious Diseases

Volumn 13, Issue 5, 2009, Pages

  Sinirtaş, Melda ^a   Akalin, Halis ^a   Gedikoǧlu, Suna ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Colistin

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; ERROR; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; NONHUMAN; SENSITIVITY ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; CULTURE MEDIA; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TURKEY;

EID: 68949186028     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.12.012     Document Type: Article

References (20)

1. Hancock R.E., and Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother 43 (1999) 1317-1323
2. Akalin H. Kolistin. ANKEM Derg 21 (2007) 26-28
3. Catchpole C.R., Andrews J.M., Brenwald N., and Wise R. A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 39 (1997) 255-260
4. Yow E.M., Tan E., Shane L., Schonfeld S., and Abu-Nassar H. Colistin (coly-mycin) in resistant bacterial infections. A clinical appraisal. Arch Intern Med 108 (1961) 64-70
5. Gales A.C., Reis A.O., and Jones R.N. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39 (2001) 183-190
6. National Committee on Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Approved standard M2-A2 S2. Wayne, PA: National Committee for Clinical Laboratory Standards; 1981.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Information supplement M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
8. Markou N., Apostolakos H., Koumoudiou C., Athanasiou M., Koutsoukou A., Alamanos I., et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7 (2003) R78-83
9. Michalopoulos A., Kasiakou S.K., Mastora Z., Rellos K., Kapaskelis A.M., and Falagas M.E. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 9 (2005) R53-R59
10. Ayan M., Durmaz R., Aktas E., and Durmaz B. Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J Hosp Infect 54 (2003) 39-45
11. Timurkaynak F., Can F., Azap O., Demirbilek M., Arslan H., and Karaman S. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 27 (2006) 224-228
12. Dizbay M., Altuncekic A., Sezer B.E., Ozdemir K., and Arman D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents 32 (2008) 29-32
13. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 50 (2006) 2946-2950
14. Arroya L.A., Garcia-Curiel A., Pachon-Ibanez M.E., Llanos A.C., Ruiz M., Pachon J., et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43 (2005) 903-905
15. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical MIC breakpoints. Available at: http://www.srga.org/eucastwt/MICTAB/MICmiscellaneous.html (accessed January 2009).
16. Rodriguez C.H., Pautaso J., Bombicino K., Vay C., and Famiglietti A. Sensitivity to colistin: evaluation of cut-off points available in disk diffusion test. Rev Argent Microbiol 36 (2004) 125-129
17. Tan T.Y., and Ng L.S. Comparison of three standardized disc susceptibility testing methods for colistin. J Antimicrob Chemother 58 (2006) 864-867
18. Galani I., Kontopidou F., Souli M., Rekatsina P.D., Koratzanis E., Deliolanis J., et al. Colistin susceptibility testing by E-test and disk diffusion methods. Int J Antimicrob Agents 31 (2008) 434-439
19. Lo-Ten-Foe J.R., de Smet A.M., Diederen B.M., Kluytmans J.A., and van Keulen P.H. Comparative evaluation of the VITEK 2, disk diffusion, E-test, broth microdilution and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 51 (2007) 3726-3730
20. Tan T.Y., and Ng S.Y. Comparison of E-test. Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 13 (2007) 541-544